[1] Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol, 2019; 15, 288−98. doi:  10.1038/s41574-019-0176-8
[2] Cani PD, Jordan BF. Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer. Nat Rev Gastroenterol Hepatol, 2018; 15, 671−82. doi:  10.1038/s41575-018-0025-6
[3] Yang J, Wei H, Zhou YF, et al. High-fat diet promotes colorectal tumorigenesis through modulating gut microbiota and metabolites. Gastroenterology, 2022; 162, 135-49. e2.
[4] Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature, 2009; 457, 480−4. doi:  10.1038/nature07540
[5] Le Chatelier E, Nielsen T, Qin JJ, et al. Richness of human gut microbiome correlates with metabolic markers. Nature, 2013; 500, 541−6. doi:  10.1038/nature12506
[6] Ley RE, Turnbaugh PJ, Klein S, et al. Human gut microbes associated with obesity. Nature, 2006; 444, 1022−3. doi:  10.1038/4441022a
[7] Amabebe E, Robert FO, Agbalalah T, et al. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism. Br J Nutr, 2020; 123, 1127−37. doi:  10.1017/S0007114520000380
[8] Zeybel M, Arif M, Li XY, et al. Multiomics analysis reveals the impact of microbiota on host metabolism in hepatic steatosis. Adv Sci, 2022; 9, 2104373. doi:  10.1002/advs.202104373
[9] Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 2013; 341, 1241214. doi:  10.1126/science.1241214
[10] Wortelboer K, de Jonge PA, Scheithauer TPM, et al. Phage-microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety. Nat Commun, 2023; 14, 5600. doi:  10.1038/s41467-023-41329-z
[11] Gutierrez MW, Mercer EM, Moossavi S, et al. Maturational patterns of the infant gut mycobiome are associated with early-life body mass index. Cell Rep Med, 2023; 4, 100928. doi:  10.1016/j.xcrm.2023.100928
[12] Baker BJ, De Anda V, Seitz KW, et al. Diversity, ecology and evolution of Archaea. Nat Microbiol, 2020; 5, 887−900. doi:  10.1038/s41564-020-0715-z
[13] Lurie-Weinberger MN, Gophna U. Archaea in and on the human body: health implications and future directions. PLoS pathogens, 2015; 11, e1004833. doi:  10.1371/journal.ppat.1004833
[14] Lecours PB, Marsolais D, Cormier Y, et al. Increased prevalence of Methanosphaera stadtmanae in inflammatory bowel diseases. PLoS One, 2014; 9, e87734. doi:  10.1371/journal.pone.0087734
[15] Coker OO, Wu WKK, Wong SH, et al. Altered gut Archaea composition and interaction with bacteria are associated with colorectal cancer. Gastroenterology, 2020; 159, 1459-70. e5.
[16] Kuehnast T, Kumpitsch C, Mohammadzadeh R, et al. Exploring the human Archaeome: its relevance for health and disease, and its complex interplay with the human immune system. FEBS J, 2025; 292, 1316−29. doi:  10.1111/febs.17123
[17] Nakamura N, Lin HC, McSweeney CS, et al. Mechanisms of microbial hydrogen disposal in the human colon and implications for health and disease. Annu Rev Food Sci Technol, 2010; 1, 363−95. doi:  10.1146/annurev.food.102308.124101
[18] Anhê FF, Zlitni S, Zhang SY, et al. Human gut microbiota after bariatric surgery alters intestinal morphology and glucose absorption in mice independently of obesity. Gut, 2023; 72, 460−71. doi:  10.1136/gutjnl-2022-328185
[19] Gasmi A, Bjørklund G, Mujawdiya PK, et al. Gut microbiota in bariatric surgery. Crit Rev Food Sci Nutr, 2023; 63, 9299−314. doi:  10.1080/10408398.2022.2067116
[20] Liu RX, Hong J, Xu XQ, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med, 2017; 23, 859−68. doi:  10.1038/nm.4358
[21] Nie XM, Chen JR, Ma XJ, et al. A metagenome-wide association study of gut microbiome and visceral fat accumulation. Comput Struct Biotechnol J, 2020; 18, 2596−609. doi:  10.1016/j.csbj.2020.09.026
[22] Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature, 2013; 498, 99−103. doi:  10.1038/nature12198
[23] Chen SF, Zhou YQ, Chen YR, et al. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics, 2018; 34, i884−90. doi:  10.1093/bioinformatics/bty560
[24] Wood DE, Lu J, Langmead B. Improved metagenomic analysis with kraken 2. Genome Biol, 2019; 20, 257. doi:  10.1186/s13059-019-1891-0
[25] Kurtzer GM, Sochat V, Bauer MW. Singularity: scientific containers for mobility of compute. PLoS One, 2017; 12, e0177459. doi:  10.1371/journal.pone.0177459
[26] Tange O. Gnu parallel: the command-line power tool. Usenix Mag, 2011; 36, 42-7.
[27] Oksanen J, Simpson GL, Blanchet FG, et al. Vegan: community ecology package; 2022.
[28] Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinf, 2011; 12, 77. doi:  10.1186/1471-2105-12-77
[29] Friedman J, Alm EJ. Inferring correlation networks from genomic survey data. PLOS Comput Biol, 2012; 8, e1002687. doi:  10.1371/journal.pcbi.1002687
[30] Wickham H, Averick M, Bryan J, et al. Welcome to the Tidyverse. J Open Source Software, 2019; 4, 1686. doi:  10.21105/joss.01686
[31] R Core Team. R: a language and environment for statistical computing 2020.
[32] Kolde R. Pheatmap: Pretty Heatmaps; 2019.
[33] Huang XW, Hu MN, Sun TT, et al. Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohorts. Cell Host Microbe, 2023; 31, 1930-43. e4.
[34] Nearing JT, Comeau AM, Langille MGI. Identifying biases and their potential solutions in human microbiome studies. Microbiome, 2021; 9, 113. doi:  10.1186/s40168-021-01059-0
[35] Allali I, Arnold JW, Roach J, et al. A comparison of sequencing platforms and bioinformatics pipelines for compositional analysis of the gut microbiome. BMC Microbiol, 2017; 17, 194. doi:  10.1186/s12866-017-1101-8
[36] Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 2006; 444, 1027−31. doi:  10.1038/nature05414
[37] Samuel BS, Gordon JI. A humanized gnotobiotic mouse model of host–archaeal–bacterial mutualism. Proc Natl Acad Sci USA, 2006; 103, 10011−6. doi:  10.1073/pnas.0602187103
[38] Gandhi A, Shah A, Jones MP, et al. Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: a systematic review and meta-analysis. Gut Microbes, 2021; 13, 1933313. doi:  10.1080/19490976.2021.1933313
[39] Volmer JG, McRae H, Morrison M. The evolving role of Methanogenic Archaea in mammalian microbiomes. Front Microbiol, 2023; 14, 1268451. doi:  10.3389/fmicb.2023.1268451
[40] Lim MY, You HJ, Yoon HS, et al. The effect of heritability and host genetics on the gut microbiota and metabolic syndrome. Gut, 2017; 66, 1031−8. doi:  10.1136/gutjnl-2015-311326
[41] Pimentel M, Mayer AG, Park S, et al. Methane production during lactulose breath test is associated with gastrointestinal disease presentation. Dig Dis Sci, 2003; 48, 86−92. doi:  10.1023/A:1021738515885
[42] Shkoporov AN, Hill C. Bacteriophages of the human gut: the “known unknown” of the microbiome. Cell Host Microbe, 2019; 25, 195−209. doi:  10.1016/j.chom.2019.01.017
[43] Lai SY, Yan Y, Pu YN, et al. Enterotypes of the human gut mycobiome. Microbiome, 2023; 11, 179. doi:  10.1186/s40168-023-01586-y
[44] Yang KL, Niu JK, Zuo T, et al. Alterations in the gut Virome in obesity and type 2 diabetes mellitus. Gastroenterology, 2021; 161, 1257-69. e13.
[45] Krawczyk A, Gosiewski T, Zapała B, et al. Alterations in intestinal Archaea composition in pediatric patients with Crohn’s disease based on next-generation sequencing – a pilot study. Gut Microbes, 2023; 15, 2276806. doi:  10.1080/19490976.2023.2276806
[46] Yang KL, Yang J, Zhang JW, et al. IDDF2021-ABS-0130 dysbiosis of gut archaea in obesity recovered after bariatric surgery. Gut, 2021; 70, A46. doi:  10.1136/gutjnl-2021-iddf.43